FMS
Fresenius Medical Care AG & Co. KGaANYSEHealthcare$22.41+0.27%ClosedMarket Cap: $12.92B
As of 2026-04-06
Valuation
P/E (TTM)
13.20
PEG
0.16
P/B
0.78
P/S
0.57
EV/EBITDA
6.19
DCF Value
$83.59
FCF Yield
15.6%
Div Yield
3.5%
Margins & Returns
Gross Margin
25.6%
Operating Margin
9.3%
Net Margin
5.0%
ROE
7.1%
ROA
6.0%
ROIC
5.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.07B | 27.4% | $594.0M | $327.0M | $0.57 | — |
| FY 2025 | $19.63B | 25.6% | $1.83B | $978.0M | $1.68 | $0.79 |
| Q3 2025 | $4.88B | 25.4% | $476.5M | $274.8M | $0.47 | — |
| Q2 2025 | $4.79B | 25.3% | $425.3M | $225.3M | $0.39 | $0.79 |
| Q1 2025 | $4.88B | 24.3% | $331.4M | $151.2M | $0.26 | — |
| Q4 2024 | $5.08B | 25.0% | $259.4M | $66.9M | $0.06 | — |
| FY 2024 | $19.34B | 24.6% | $1.39B | $537.9M | $0.92 | $0.63 |
| Q3 2024 | $4.76B | 24.1% | $463.0M | $213.0M | $0.19 | — |
| Q2 2024 | $4.77B | 24.5% | $425.0M | $187.0M | $0.16 | $0.63 |
| Q1 2024 | $4.72B | 24.8% | $246.0M | $71.0M | $0.06 | — |
| Q4 2023 | $4.99B | 27.1% | $427.6M | $187.9M | $0.22 | — |
| FY 2023 | $19.45B | 25.3% | $1.37B | $499.0M | $0.85 | $0.62 |